MicroMed Technology
Health tech firm offering a compact, cost-effective heart assist device, developed with NASA, for transplant wait-list patients.
Founded
1998Health tech firm offering a compact, cost-effective heart assist device, developed with NASA, for transplant wait-list patients.
MicroMed Technology, founded to address the critical need for heart transplant solutions, focuses on developing advanced health technology. Its core mission is to provide life-saving devices for patients awaiting heart transplants. The company’s flagship product, the MicroMed DeBakey VAD®, is a compact, cost-effective heart assist device created in collaboration with Dr. Michael DeBakey, Dr. George Noon, and NASA. This device is designed to sustain patients until a donor heart becomes available, significantly improving their survival chances.
Notable figures affiliated with MicroMed Technology include renowned cardiovascular surgeons Dr. Michael DeBakey and Dr. George Noon. The company has achieved significant milestones, including the development of a ventricular assist device that is a fraction of the size of traditional pulsatile products. This innovation has had a profound impact on the healthcare industry by providing a silent, lightweight solution for heart failure patients, enhancing their quality of life while they await transplants.
Companies similar to MicroMed Technology include Micro Interventional Devices, Micro Medical Solutions, Vadovations and Abiomed.
MicroMed Technology was founded in 1998.
MicroMed Technology's headquarters is located in Houston, TX, US.
MicroMed Technology's most recent funding round was for $23M (USD) in October 2002.
As of Oct 2, 2002, MicroMed Technology has disclosed funding of $40.6M (USD). Undisclosed round amounts are excluded.
MicroMed Technology has 13 employees as of Feb 5, 2024.
abiomed.com
